$28.52
-1.06-3.58%
Last update: Aug 27, 3:03 PM
Maze Therapeutics (MAZE) institutional and insider ownership, recent insider transactions and ownership breakdown.
Shares Outstanding
55.549M
Shares Float
49.333M
Insider Shares Owned
608.807K
Insider % Owned
1.1%
Institutional Shares Held
13.422M
Institutional % Held
24.2%
Ownership Breakdown
Net Insider Activity by Month
Purchases (90d)
0
Sales (90d)
4
$2.9M total
Net Activity
Net Selling
Net Value (90d)
-$2.9M
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $19.01 | $277K |
| Aug 3, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 34.501K | $26.73 | $922K |
| Jul 29, 2026 | Atul Dandekar | CSBO | SELL-OPTIONS | — | $18.88 | $127K |
| Jul 1, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $20.16 | $285K |
| Jul 1, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 34.501K | $29.98 | $1.0M |
| Jun 29, 2026 | Atul Dandekar | CSBO | SELL-OPTIONS | — | $19.22 | $132K |
| Jun 22, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 27.858K | $26.04 | $725K |
| Jun 1, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 6.643K | $26.20 | $174K |
| Jun 1, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $18.04 | $226K |
| May 29, 2026 | Atul Dandekar | CSBO | SELL-OPTIONS | — | $18.38 | $119K |
| May 22, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 32.564K | $26.01 | $847K |
| May 15, 2026 | Jason Coloma V | CHIEF EXECUTIVE OFFICER | SELL | 1.938K | $26.00 | $50K |
| May 14, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $18.32 | $237K |
| Apr 29, 2026 | Atul Dandekar | CSBO | SELL-OPTIONS | — | $17.90 | $112K |
| Apr 1, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $19.94 | $286K |
| Apr 1, 2026 | Amy Bachrodt | SVP, FINANCE | SELL-OPTIONS | — | $19.93 | $48K |
| Mar 30, 2026 | Atul Dandekar | CSBO | SELL-OPTIONS | — | $19.88 | $142K |
| Mar 20, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $29.76 | $580K |
| Mar 10, 2026 | Harold Bernstein | PRESIDENT, R&D & CMO | SELL-OPTIONS | — | $30.44 | $1.2M |
| Mar 2, 2026 | Amy Bachrodt | SVP, FINANCE | SELL-OPTIONS | — | $27.81 | $174K |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.